USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Medical Laser Research & Devel
Address:
Po Box 539
Malden, MA 02148
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $246,034.00 4
SBIR Phase II $282,000.00 1

Award List:

NONCHARRING HEMOSTATIC SURGICAL LASER SYSTEM

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Irving Itzkan , Principal Investigator
Abstract:
N/a

NONCHARRING HEMOSTATIC SURGICAL LASER SYSTEM

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$282,000.00
Agency:
HHS
Principal Investigator:
Irving Itzkan , Principal Investigator
Abstract:
The aim of this program is to develop a surgical laser system which can remove tumors or other tissue with minimal blood loss, precision, and minimal damage to adjacent tissue. the phase i program is a demonstration of laser control parameters required for hemostatic action without tissue damage.… More

PREVENTION OF GRAVITY INDUCED LOSS OF CONSCIOUSNESS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$69,985.00
Agency / Branch:
DOD / USAF
Principal Investigator:
Donna Bourgelais
Abstract:
A novel approach for the prevention of g-loc is proposed. a process for temporarily increasing the oxygen available to tissue in blood flow compromised areas will be demonstrated in phase i. phase ii will include optimization of the process and the design and fabrication of prototype anti-g-loc… More

BROAD PROTECTION AGAINST INFECTIOUS PATHOGENS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$76,049.00
Agency / Branch:
DOD / DARPA
Principal Investigator:
Donna Bourgelais , Principal Investigator
Abstract:
A method is proposed for conferring broad spectrum immunity without undesirable side effects. protection against a wide variety of bacteria, viruses and fungi are included. anticipated benefits/potential commercial applications - in addition to the obvious military benefit, this approach would… More

ACCELERATED OSSEOINTEGRATION

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Bourgelais, Donna B , Principal Investigator
Abstract:
The program will investigate the effect on bone growth of photolytic oxygen release. by irradiating tissue with light in the appropriate wavelength and irradiance range, increased oxygen release in the capillary structure may be achieved, thus increasing the oxygen actually available to tissue and… More